NUTROPIN Side Effects

7013934-9 | Convulsion
on Sep 14, 2010 Male patient from UNITED STATES , weighting 105.8 lb, was diagnosed with growth hormone deficiency and was treated with Nutropin (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Nutropin dosage: 2.9 Mg, Qd.

6943679-2 | Convulsion
Patient was taking Nutropin (View Usage). Patient had the following side effects: convulsion on Aug 19, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 105.8 lb, was diagnosed with growth hormone deficiency, noonan syndrome and. Nutropin dosage: 2.9 Mg, Qd.

6827253-4 | Abdominal Discomfort, Headache, Migraine
Adverse event was reported on Jun 29, 2010 by a Male patient taking Nutropin (View Usage) (Dosage: ) . Location: UNITED STATES , 13 years of age, After Nutropin was administered, patient had the following side effects: abdominal discomfort, headache (What is headache?), migraine (What is migraine?).

6813726-7 | Autoimmune Thyroiditis
on Jun 22, 2010 Male patient from UNITED STATES , weighting 69.23 lb, was diagnosed with body height below normal, hypothyroidism and was treated with Nutropin (View Usage). Patient experienced the following unwanted or unexpected effects: autoimmune thyroiditis. Nutropin dosage: 1.6 Mg, Qd. During the same period patient was treated with SYNTHROID (75 Unk, Qd) (View Synthroid Review and Synthroid Label ).


6782741-4 | Abdominal Pain, Blood Immunoglobulin E Increased, Eosinophilia
on Jun 10, 2010 Female patient from UNITED KINGDOM , child 12 years of age, was treated with Nutropin (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), blood immunoglobulin e increased, eosinophilia. Nutropin dosage: .

6747994-7 | Autoimmune Thyroiditis
Patient was taking Nutropin (View Usage). After Nutropin was administered, patient had the following side effects: autoimmune thyroiditis on May 21, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 69.23 lb, was diagnosed with body height below normal and. Nutropin dosage: 1.6 Mg, Qd. During the same period patient was treated with SYNTHROID (75 Unk, Qd) (View Synthroid Review and Synthroid Label ).

6734135-5 | Autoimmune Thyroiditis
Adverse event was reported on May 10, 2010 by a Male patient taking Nutropin (View Usage) (Dosage: 1.6 Mg, Qd) was diagnosed with body height below normal and. Location: UNITED STATES , weighting 69.23 lb, Patient experienced the following unwanted or unexpected effects: autoimmune thyroiditis. During the same period patient was treated with SYNTHROID (75 Unk, Qd) (View Synthroid Review and Synthroid Label ).

6728698-3 | Acute Leukaemia
on May 07, 2010 Male patient from DENMARK , 14 years of age, was treated with Nutropin (View Usage). Patient had the following side effects: acute leukaemia. Nutropin dosage: .

6726487-7 | Malignant Melanoma
on May 07, 2010 Female patient from ITALY , 26 years of age, weighting 105.8 lb, was diagnosed with growth hormone deficiency and was treated with Nutropin (View Usage). After Nutropin was administered, patient had the following side effects: malignant melanoma. Nutropin dosage: 0.8 Mg, Qd. During the same period patient was treated with ETHINYL ESTRADIOL (20 A?g, Qdx21) (View Ethinyl Estradiol Review and Ethinyl Estradiol Label ), PROGESTIN (75 A?g, Qd) (View Progestin Review and Progestin Label ), LEVOTHYROXINE SODIUM (25 A?g, Qd) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6710355-0 | Osteochondrosis
Patient was taking Nutropin (View Usage). Patient experienced the following unwanted or unexpected effects: osteochondrosis on Apr 25, 2010 from UNITED STATES Additional patient health information: Male patient , child 12 years of age, . Nutropin dosage: Unk.

6701055-1 | Malignant Melanoma
Adverse event was reported on Apr 19, 2010 by a Female patient taking Nutropin (View Usage) (Dosage: 0.8 Mg, Qd) was diagnosed with growth hormone deficiency and. Location: ITALY , 26 years of age, weighting 105.8 lb, Patient had the following side effects: malignant melanoma. During the same period patient was treated with ETHINYL ESTRADIOL (20 A?g, Qdx21) (View Ethinyl Estradiol Review and Ethinyl Estradiol Label ), PROGESTIN (75 A?g, Qd) (View Progestin Review and Progestin Label ), LEVOTHYROXINE (25 A?g, Qd) (View Levothyroxine Review and Levothyroxine Label ).

6685171-9 | Craniopharyngioma
on Apr 09, 2010 Male patient from UNITED KINGDOM , child 10 years of age, was diagnosed with growth hormone deficiency and was treated with Nutropin (View Usage). After Nutropin was administered, patient had the following side effects: craniopharyngioma. Nutropin dosage: 0.025 Mg/kg, Qd. Patient was hospitalized.

6636527-1 | Hyperglycaemia
on Nov 05, 2009 Male patient from UNITED STATES , 18 years of age, weighting 269.0 lb, was diagnosed with growth hormone deficiency and was treated with Nutropin (View Usage). Patient experienced the following unwanted or unexpected effects: hyperglycaemia. Nutropin dosage: Subcutaneous. During the same period patient was treated with INSULIN (INSULIN) (View Insulin (insulin) Review and Insulin (insulin) Label ).

6569979-6 | Angioedema, Urticaria
Patient was taking Nutropin (View Usage). Patient had the following side effects: angioedema, urticaria on Jan 28, 2010 from UNITED STATES Additional patient health information: Male patient , 36 years of age, weighting 215.4 lb, was diagnosed with growth hormone deficiency, urticaria, angioedema and. Nutropin dosage: 1 Iu, Bid. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), KEFLEX (View Keflex Review and Keflex Label ).

6543341-4 | Blood Pressure Increased, Burning Sensation, Dysgeusia, Hyperhidrosis
Adverse event was reported on Jan 12, 2010 by a Male patient taking Nutropin (View Usage) (Dosage: 10 Mg, Weekly) was diagnosed with hypopituitarism and. Location: UNITED KINGDOM , 55 years of age, After Nutropin was administered, patient had the following side effects: blood pressure increased, burning sensation, dysgeusia, hyperhidrosis. During the same period patient was treated with TESTOSTERONE UNDECANOATE (Unk) (View Testosterone Undecanoate Review and Testosterone Undecanoate Label ), ATORVASTATIN (80 Mg, Unk) (View Atorvastatin Review and Atorvastatin Label ), CLOPIDOGREL (75 Mg, Unk) (View Clopidogrel Review and Clopidogrel Label ), FENOFIBRATE (160 Mg, Unk) (View Fenofibrate Review and Fenofibrate Label ), METFORMIN HYDROCHLORIDE (3000 Mg, Unk) (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), MOVELAT (Unk) (View Movelat Review and Movelat Label ), NOVOMIX (136 Iu, Unk) (View Novomix Review and Novomix Label ), ROSIGLITAZONE MALEATE (4 Mg, Unk) (View Rosiglitazone Maleate Review and Rosiglitazone Maleate Label ).

6540455-X | Blood Pressure Increased, Burning Sensation, Dysgeusia, Hyperhidrosis
on Jan 07, 2010 Male patient from DENMARK , 55 years of age, was diagnosed with hypopituitarism and was treated with Nutropin (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, burning sensation, dysgeusia, hyperhidrosis. Nutropin dosage: Subcutaneous. During the same period patient was treated with NEBIDO (View Nebido Review and Nebido Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), HEPARIN (View Heparin Review and Heparin Label ), INSULIN ASPART (View Insulin Aspart Review and Insulin Aspart Label ), ROSIGLITAZONE MALEATE (View Rosiglitazone Maleate Review and Rosiglitazone Maleate Label ).

6524264-3 | Arthralgia, Joint Dislocation
on Dec 23, 2009 Male patient from UNITED STATES , weighting 120.2 lb, was diagnosed with body height below normal and was treated with Nutropin (View Usage). Patient had the following side effects: arthralgia, joint dislocation. Nutropin dosage: 2.2 Mg, Qd.

6524175-3 | Arteriovenous Malformation, Haemangioma
Patient was taking Nutropin (View Usage). After Nutropin was administered, patient had the following side effects: arteriovenous malformation (What is arteriovenous malformation?), haemangioma on Dec 21, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 80.25 lb, was diagnosed with growth hormone deficiency and. Nutropin dosage: 1.4 Mg, Qd.

6506358-1 | Angioedema, Urticaria
Adverse event was reported on Dec 09, 2009 by a Male patient taking Nutropin (View Usage) (Dosage: 1 Iu, Bid) was diagnosed with growth hormone deficiency, urticaria, angioedema and. Location: UNITED STATES , 36 years of age, weighting 215.4 lb, Patient experienced the following unwanted or unexpected effects: angioedema, urticaria. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ).

6471041-8 | Gait Disturbance, Osteochondrosis, X-ray Abnormal
on Nov 23, 2009 Male patient from UNITED STATES , weighting 158.5 lb, was diagnosed with growth retardation and was treated with Nutropin (View Usage). Patient had the following side effects: gait disturbance, osteochondrosis, x-ray abnormal. Nutropin dosage: 0.9 Mg, Qd. During the same period patient was treated with METADATE CD (30 Mg, Qd) (View Metadate Cd Review and Metadate Cd Label ).

6457867-5 | Hypoaesthesia, Nerve Compression, Pain In Extremity, Paraesthesia
on Nov 19, 2009 Male patient from UNITED STATES , weighting 88.18 lb, was diagnosed with growth hormone deficiency and was treated with Nutropin (View Usage). After Nutropin was administered, patient had the following side effects: hypoaesthesia, nerve compression, pain in extremity, paraesthesia. Nutropin dosage: 2.2 Mg, 7/week.

6449577-5 | Bone Sarcoma
Patient was taking Nutropin (View Usage). Patient experienced the following unwanted or unexpected effects: bone sarcoma on Nov 12, 2009 from UNITED STATES Additional patient health information: Male patient , 15 years of age, was diagnosed with growth hormone deficiency and. Nutropin dosage: 0.9 Mg, Qd. Patient was hospitalized.

6443904-0 | Convulsion, Headache
Adverse event was reported on Nov 05, 2009 by a Female patient taking Nutropin (View Usage) (Dosage: 0.3 Mg, Qd) was diagnosed with growth hormone deficiency, diabetes insipidus (What is diabetes insipidus?) and. Location: UNITED KINGDOM , 33 years of age, Patient had the following side effects: convulsion, headache (What is headache?). During the same period patient was treated with VASOPRESSIN (Unk) (View Vasopressin Review and Vasopressin Label ), CORTISONE (Unk) (View Cortisone Review and Cortisone Label ), THYROID REPLACEMENT NOS (View Thyroid Replacement Nos Review and Thyroid Replacement Nos Label ), HORMONE NOS (Unk) (View Hormone Nos Review and Hormone Nos Label ). Patient was hospitalized.

6435302-0 | Asthenia, Cough, Epistaxis
on Oct 29, 2009 Female patient from UNITED KINGDOM , weighting 37.48 lb, was diagnosed with growth hormone deficiency and was treated with Nutropin (View Usage). After Nutropin was administered, patient had the following side effects: asthenia, cough, epistaxis. Nutropin dosage: 0.04 Mg/kg, Qd.

6431538-3 | Convulsion, Headache
on Oct 29, 2009 Female patient from UNITED KINGDOM , 33 years of age, was diagnosed with growth hormone deficiency, diabetes insipidus (What is diabetes insipidus?) and was treated with Nutropin (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, headache (What is headache?). Nutropin dosage: 0.3 Mg, Qd. During the same period patient was treated with VASOPRESSIN (Unk) (View Vasopressin Review and Vasopressin Label ), CORTISONE (Unk) (View Cortisone Review and Cortisone Label ), THYROID REPLACEMENT NOS (View Thyroid Replacement Nos Review and Thyroid Replacement Nos Label ), HORMONE NOS (Unk) (View Hormone Nos Review and Hormone Nos Label ). Patient was hospitalized.

6402512-8 | Convulsion
Patient was taking Nutropin (View Usage). Patient had the following side effects: convulsion on Oct 09, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 33 years of age, was diagnosed with growth hormone deficiency, diabetes insipidus (What is diabetes insipidus?) and. Nutropin dosage: 0.3 Mg, Qd. During the same period patient was treated with VASOPRESSIN (Unk) (View Vasopressin Review and Vasopressin Label ). Patient was hospitalized.

6308376-5 | Breast Cancer
Adverse event was reported on Aug 05, 2009 by a Female patient taking Nutropin (View Usage) (Dosage: 0.5 Mg, Unk) was diagnosed with growth hormone deficiency and. Location: UNITED KINGDOM , 58 years of age, After Nutropin was administered, patient had the following side effects: breast cancer (What is breast cancer?).

6300206-0 | Neoplasm Progression
on Aug 03, 2009 Female patient from UNITED KINGDOM , 76 years of age, was diagnosed with hypopituitarism and was treated with Nutropin (View Usage). Patient experienced the following unwanted or unexpected effects: neoplasm progression. Nutropin dosage: Unk.

6292800-0 | Medulloblastoma Recurrent
on Jul 21, 2009 Male patient from UNITED KINGDOM , weighting 89.51 lb, was diagnosed with growth hormone deficiency and was treated with Nutropin (View Usage). Patient had the following side effects: medulloblastoma recurrent. Nutropin dosage: 1 Mg, Unk. Patient was hospitalized.

6268791-5 | Eating Disorder, Ileus, Vomiting
Patient was taking Nutropin (View Usage). After Nutropin was administered, patient had the following side effects: eating disorder (What is eating disorder?), ileus, vomiting on Jul 08, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 124.1 lb, was diagnosed with prader-willi syndrome (What is prader-willi syndrome?), growth hormone deficiency and. Nutropin dosage: 2.5 Mg, 6/week. During the same period patient was treated with LEVOTHYROXINE SODIUM (50 A?g, Qd) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6251591-X | Renal Cancer
Adverse event was reported on Jun 24, 2009 by a Male patient taking Nutropin (View Usage) (Dosage: 3 Iu, Qd) was diagnosed with renal failure chronic, body height below normal and. Location: SWEDEN , 15 years of age, Patient experienced the following unwanted or unexpected effects: renal cancer. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), CORTICOSTEROIDS (UNK INGREDIENTS) (View Corticosteroids (unk Ingredients) Review and Corticosteroids (unk Ingredients) Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6251571-4 | Renal Cancer
on Jun 24, 2009 Male patient from GERMANY , 14 years of age, was diagnosed with growth hormone deficiency and was treated with Nutropin (View Usage). Patient had the following side effects: renal cancer. Nutropin dosage: 0.04 Mg/kg, Qd.

6251535-0 | Renal Cancer
on Jun 24, 2009 Male patient from SWEDEN , 13 years of age, was diagnosed with renal failure chronic, growth retardation and was treated with Nutropin (View Usage). After Nutropin was administered, patient had the following side effects: renal cancer. Nutropin dosage: . During the same period patient was treated with CYCLOSPORINE (160 Mg, Qd) (View Cyclosporine Review and Cyclosporine Label ), PREDNISOLONE (10 Mg, Qod) (View Prednisolone Review and Prednisolone Label ), CORTICOSTEROIDS (UNK INGREDIENTS) (View Corticosteroids (unk Ingredients) Review and Corticosteroids (unk Ingredients) Label ).

6251534-9 | Renal Cancer
Patient was taking Nutropin (View Usage). Patient experienced the following unwanted or unexpected effects: renal cancer on Jun 24, 2009 from GERMANY Additional patient health information: Male patient , 18 years of age, was diagnosed with renal failure chronic and. Nutropin dosage: . During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), CORTICOSTEROIDS (UNK INGREDIENTS) (View Corticosteroids (unk Ingredients) Review and Corticosteroids (unk Ingredients) Label ), ORTHOCLONE OKT3 (View Orthoclone Okt3 Review and Orthoclone Okt3 Label ).

6251525-8 | Renal Cancer
Adverse event was reported on Jun 24, 2009 by a Female patient taking Nutropin (View Usage) (Dosage: ) was diagnosed with renal failure chronic and. Location: GERMANY , 20 years of age, Patient had the following side effects: renal cancer. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), CORTICOSTEROIDS (UNK INGREDIENTS) (View Corticosteroids (unk Ingredients) Review and Corticosteroids (unk Ingredients) Label ).

6251524-6 | Renal Cancer
on Jun 24, 2009 Male patient from GERMANY , child 6 years of age, was diagnosed with growth hormone deficiency and was treated with Nutropin (View Usage). After Nutropin was administered, patient had the following side effects: renal cancer. Nutropin dosage: 1.3 Mg/m2, Qd.

6243891-4 | Colon Cancer Metastatic
on Jun 16, 2009 Male patient from UNITED KINGDOM , 68 years of age, was treated with Nutropin (View Usage). Patient experienced the following unwanted or unexpected effects: colon cancer metastatic. Nutropin dosage: 0.6 Mg, Bid. During the same period patient was treated with PREDNISONE (6 Mg, Qd) (View Prednisone Review and Prednisone Label ), MESALAMINE (View Mesalamine Review and Mesalamine Label ), TESTOSTERONE (200 Mg, 1/week) (View Testosterone Review and Testosterone Label ), DEHYDROEPIANDROSTERONE (100 Mg, Qd) (View Dehydroepiandrosterone Review and Dehydroepiandrosterone Label ). Patient was hospitalized.

6243736-2 | Colon Cancer Metastatic
Patient was taking Nutropin (View Usage). Patient had the following side effects: colon cancer metastatic on Jun 16, 2009 from UNITED STATES Additional patient health information: Male patient , 68 years of age, . Nutropin dosage: 0.6 Mg, Bid. During the same period patient was treated with TESTOSTERONE (200 Mg, 1/week) (View Testosterone Review and Testosterone Label ), DEHYDROEPIANDROSTERONE (100 Mg, Qd) (View Dehydroepiandrosterone Review and Dehydroepiandrosterone Label ), PREDNISONE (6 Mg, Qd) (View Prednisone Review and Prednisone Label ), MESALAMINE (View Mesalamine Review and Mesalamine Label ).

6230071-1 | Renal Cancer
Adverse event was reported on Jun 01, 2009 by a Male patient taking Nutropin (View Usage) (Dosage: 3 Iu, Qd) was diagnosed with renal failure chronic, body height below normal and. Location: SWEDEN , 15 years of age, After Nutropin was administered, patient had the following side effects: renal cancer. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), CORTICOSTEROIDS (UNK INGREDIENTS) (View Corticosteroids (unk Ingredients) Review and Corticosteroids (unk Ingredients) Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6230068-1 | Renal Cancer
on Jun 01, 2009 Male patient from GERMANY , 14 years of age, was diagnosed with growth hormone deficiency and was treated with Nutropin (View Usage). Patient experienced the following unwanted or unexpected effects: renal cancer. Nutropin dosage: 0.04 Mg/kg, Qd.

6230067-X | Renal Cancer
on Jun 01, 2009 Male patient from SWEDEN , 13 years of age, was diagnosed with renal failure chronic, growth retardation and was treated with Nutropin (View Usage). Patient had the following side effects: renal cancer. Nutropin dosage: . During the same period patient was treated with CYCLOSPORINE (160 Mg, Qd) (View Cyclosporine Review and Cyclosporine Label ), PREDNISOLONE (10 Mg, Qod) (View Prednisolone Review and Prednisolone Label ), CORTICOSTEROIDS (UNK INGREDIENTS) (View Corticosteroids (unk Ingredients) Review and Corticosteroids (unk Ingredients) Label ).

6230066-8 | Renal Cancer
Patient was taking Nutropin (View Usage). After Nutropin was administered, patient had the following side effects: renal cancer on Jun 01, 2009 from GERMANY Additional patient health information: Male patient , 18 years of age, was diagnosed with renal failure chronic and. Nutropin dosage: . During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), CORTICOSTEROIDS (UNK INGREDIENTS) (View Corticosteroids (unk Ingredients) Review and Corticosteroids (unk Ingredients) Label ), ORTHOCLONE OKT3 (View Orthoclone Okt3 Review and Orthoclone Okt3 Label ).

6230065-6 | Renal Cancer
Adverse event was reported on Jun 01, 2009 by a Male patient taking Nutropin (View Usage) (Dosage: 1.3 Mg/m2, Qd) was diagnosed with growth hormone deficiency and. Location: GERMANY , child 6 years of age, Patient experienced the following unwanted or unexpected effects: renal cancer.

6230064-4 | Renal Cancer
on Jun 01, 2009 Female patient from GERMANY , 20 years of age, was diagnosed with renal failure chronic and was treated with Nutropin (View Usage). Patient had the following side effects: renal cancer. Nutropin dosage: . During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), CORTICOSTEROIDS (UNK INGREDIENTS) (View Corticosteroids (unk Ingredients) Review and Corticosteroids (unk Ingredients) Label ).

6194042-6 | Colon Cancer Metastatic
on May 08, 2009 Male patient from UNITED KINGDOM , 68 years of age, was treated with Nutropin (View Usage). After Nutropin was administered, patient had the following side effects: colon cancer metastatic. Nutropin dosage: 0.6 Mg, Bid. During the same period patient was treated with PREDNISONE (6 Mg, Qd) (View Prednisone Review and Prednisone Label ), MESALAMINE (View Mesalamine Review and Mesalamine Label ), TESTOSTERONE (200 Mg, 1/week) (View Testosterone Review and Testosterone Label ), DEHYDROEPIANDROSTERONE (100 Mg, Qd) (View Dehydroepiandrosterone Review and Dehydroepiandrosterone Label ). Patient was hospitalized.

6193528-8 | Macrogenia
Patient was taking Nutropin (View Usage). Patient experienced the following unwanted or unexpected effects: macrogenia on May 08, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 141.0 lb, was diagnosed with growth hormone deficiency and. Nutropin dosage: 3.7 Mg, Qd.

6185549-6 | Colon Cancer Metastatic
Adverse event was reported on May 01, 2009 by a Male patient taking Nutropin (View Usage) (Dosage: 0.6 Mg, Bid) . Location: UNITED KINGDOM , 68 years of age, Patient had the following side effects: colon cancer metastatic. During the same period patient was treated with PREDNISONE (6 Mg, Qd) (View Prednisone Review and Prednisone Label ), MESALAMINE (View Mesalamine Review and Mesalamine Label ), TESTOSTERONE (200 Mg, 1/week) (View Testosterone Review and Testosterone Label ), DEHYDROEPIANDROSTERONE (100 Mg, Qd) (View Dehydroepiandrosterone Review and Dehydroepiandrosterone Label ). Patient was hospitalized.

6183029-5 | Colon Cancer Metastatic
on Apr 28, 2009 Male patient from UNITED STATES , 68 years of age, was treated with Nutropin (View Usage). After Nutropin was administered, patient had the following side effects: colon cancer metastatic. Nutropin dosage: 0.6 Mg, Bid. During the same period patient was treated with TESTOSTERONE (200 Mg, 1/week) (View Testosterone Review and Testosterone Label ), DEHYDROEPIANDROSTERONE (100 Mg, Qd) (View Dehydroepiandrosterone Review and Dehydroepiandrosterone Label ), PREDNISONE (6 Mg, Qd) (View Prednisone Review and Prednisone Label ), MESALAMINE (View Mesalamine Review and Mesalamine Label ).

6174378-5 | Colon Cancer Metastatic
on Apr 22, 2009 Male patient from UNITED STATES , 68 years of age, was treated with Nutropin (View Usage). Patient experienced the following unwanted or unexpected effects: colon cancer metastatic. Nutropin dosage: 0.6 Mg, Bid. During the same period patient was treated with TESTOSTERONE (200 Mg, 1/week) (View Testosterone Review and Testosterone Label ), DEHYDROEPIANDROSTERONE (100 Mg, Qd) (View Dehydroepiandrosterone Review and Dehydroepiandrosterone Label ), PREDNISONE (6 Mg, Qd) (View Prednisone Review and Prednisone Label ), MESALAMINE (View Mesalamine Review and Mesalamine Label ).

6141982-X | Myocardial Infarction
Patient was taking Nutropin (View Usage). Patient had the following side effects: myocardial infarction on Mar 23, 2009 from SWEDEN Additional patient health information: Female patient , 68 years of age, was diagnosed with growth hormone deficiency and. Nutropin dosage: .